Aruna Bio to Present at BIO International Convention 2024
28 May 2024
Aruna Bio to Present at BIO International Convention 2024
BOSTON and ATHENS, Ga., May 28, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
Conference and presentation details are as follows:
BIO International Convention – June 3-6, 2024
Format:Corporate Presentation Date:Wednesday, June 5, 2024 Time:3:15 PM PT Location:Theater 4, San Diego Convention Center, California
If you are interested in meeting with management during the conference, please register for the convention here and request to meet with Aruna by clicking this link or reach out to Aruna directly by contacting Noah Gilman, Senior Business Development Associate at ngilman@arunabio.com. For any questions, please contact your conference representative.
About Aruna Bio
Aruna Bio is revolutionizing CNS treatment with its proprietary neural exosome platform, targeting neurological conditions such as ALS, Alzheimer's, and stroke. Their lead product, AB126, demonstrates multiple biological activities, including crossing the blood-brain barrier, neuroprotection, and reducing neuro-inflammation, with potential for broad applicability across neurological diseases. The company's in-house cGMP facility supports their pipeline from early development to clinical trials. Aruna Bio's strategic approach includes leveraging their platform for drug delivery and exploring combination therapies, setting a foundation for addressing unmet needs in CNS treatment.
Investor Contact:
Corey Davis, Ph.D.
LifeSci Advisors
212-915-2577
cdavis@lifesciadvisors.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.